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Abstract 
Activation of the growth factors pathways is involved in cell growth and proliferation 
and is associated with carcinogenesis. Many studies have shown an increase in blood growth 
factors concentrations after training. On the other hand, numerous organisations recommend 
physical activity in cancer therapy and prophylaxis. This two phenomena may actually cause 
confusion. The aim of this paper was to present findings on the significance of physical 
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activity in course of neoplastic disease and dispel doubts concerning its role in cancer 
treatment. 
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Short article full-text: 
Cancer is not only a growth of autonomously proliferating cells but other, non-
malignant structures also are a functional part of the disease. Immune cells, fibroblasts, 
specialized mesenchymal cells and microvasculature together build up the tumour 
microenvironment and have functional interactions with neoplastic cells. Through metabolic 
interactions, involving machinery consisted of hormones, cytokines and further signalling 
molecules, healthy cells and tissues actively participate in tumour proliferation. Normal cells 
affect a tumour via signalling pathways. Aberrations in homeostatic regulation exert a 
significant influence on the course of the disease. Research conducted on aforementioned 
relations leads to their potential employment in therapy. [1, 2]. In this paper, we will focus on 
growth factors secreted under the influence of increased physical activity and their potential 
effects on carcinogenesis and tumour proliferation processes. 
Growth factors are relatively small proteins that exhibit activity as promoters of cell 
proliferation. They regulate the embryonic development as one of the main stimuli for tissue 
differentiation. Subsequently, they have a regulatory influence on growth throughout all 
ontogenesis. Unlike the hormones secreted by the specialised organs, growth factors are 
produced by almost all known cells of the human body. The binding of growth factors to 
specific membrane receptors (in some cases - nuclear) initiates the activation of numerous 
signalling pathways leading to the transcription of genes responsible for processes of 
proliferation and differentiation. The complexity of the signalling action is determined by the 
abundance of pathways that modulate the stimulus. Due to aforementioned features, as well as 
involvement in acute phase of inflammation and other immune-derived pathways they are 
considered important tumour growth modulators [1-3]. Insulin-like growth factors (IGFs) 
present well-known mechanism of action among the numerous signal molecules, accordingly 
we will focus on their input in physical activity potential impact on cancer development and 
prophylaxis.  
IGFs are endocrine, autocrine and paracrine stimulators of mitogenesis, survival and 
cellular transformation, therefore they are considered as important regulators of the cell cycle. 
Their actions are mediated through the type 1 IGF-receptor (IGF-1R), a tyrosine kinase that 
resembles the insulin receptor. The bioavailability of free IGF for interaction with the IGF-1R 
 303 
is modulated by the insulin-like growth factor-binding proteins (IGFBPs). IGFBPs, especially 
IGFBP-3, also have IGF-independent effects on cell growth. IGFBP-3 also constitutes a 
component of cycles that result in subsequent inhibition of growth or implication of a block 
on the path to programmed cell death [3, 4]. Other IGFBPs are involved in regulation of 
signalling axis. Not all mechanisms are understood. Their multitude of functions makes them 
an interesting research field, especially in oncology. For example: IGFBP5 is a specific 
inhibitor of angiogenesis stimulated by VEGF - vascular endothelial growth factor. By 
slowing down the angiogenesis, IGFBP5 inhibits tumour growth [INHI3]. IGF-1 and IGF-2 
are the only known proteins in the family of insulin-like growth factors. The gene encoding 
them evolved from a common precursor by duplication. The vast majority of IGF is produced 
in hepatocytes as a response to growth hormone (GH) stimulation. Significant pool of IGFs is 
synthesized in the bone by stimulation with parathyroid hormone. IGFBPs are also produced 
in the liver. Because of the structural analogy with the insulin, free IGFs induces a 
hypoglycaemic effect. Interaction with insulin receptors does not occur while the agent is 
bound to its transporting protein. More than 90% of circulating insulin-like growth factors are 
bound with IGFBP-3. The remaining pool is associated by other transport proteins, and only 
1% circulate in free form. This is due to the short half-life of the free IGF, which ranges from 
10 minutes to several hours. There is a correlation between the amount of bioavailable IGFs 
(ie associated with the carrier) and the growth of tissues - especially muscle tissue, which is 
the most responsive to physical activity and nutritional deficiencies. IGF stimulates collagen 
synthesis and induces the development of oligodendrocytes. Numerous studies have 
demonstrated the stimulating effect of IGF on tumour cells cultured in vitro [2-5]. 
Studies conducted in a randomized population of healthy subjects have shown an 
increase in bioavailable IGF concentrations after training. Exercises were based on the 
standard physical preparation program for US soldiers. After a period of eight weeks of 
regular activity, significant increases in IGFBP-3 and IGFBP-2 concentrations were observed 
in the serum of subjects [5]. However, what should be noted is that the concentration of 
IGFBPs in the blood stream decreases in the state of energy shortage. Malnutrition, fasting, 
and pathological conditions exert a significant influence on homeostasis of growth factors. In 
these circumstances catabolic processes dominates the metabolome which results in release of 
substrates necessary for survival. The example of the phoenomenon is exhaustion of the body 
in cachexia, when the serum IGF levels in the patient are significantly reduced. The analogy 
in the construction of IGF and insulin is not accidental and the mutual regulatory pathways 
are closely linked [5, 7, 9]. 
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Physical activity is most often defined as an increase in energy expenditure of the 
body resulting from increased skeletal muscle function. Its metabolic effect is the energy 
consumption, utilisation of reserves and the proliferation of tissues - mainly muscular and 
connective - occurring with proper access to the nutritious resource. Physical activity is an 
important health-promoting behavior, but its association with cancer therapy remains poorly 
understood [7]. 
International Agency for Research on Cancer stated that obesity is the leading cause of 
one third of colorectal, 4ast, endometrial, esophageal, and renal cancers. The studies that gave 
rise to the above statements are based on statistical data including BMI and lifestyle of 
oncological patients [8]. A review of more than 70 studies on the impact of physical activity 
on the prevention of 4ast cancer has made it possible to estimate a 25% reduction in the 
incidence of the disease. The problem of type, quantity and dosage of exercises was also 
discussed. The recreational activities, which do not cause excessive burdens on the body, are 
considered the best. The authors recommend conducting further research to better understand 
the mechanisms of the positive effect of exercise on disease prevention. Very similar results 
were obtained when analyzing the effects of moderate exercise in the prevention of colorectal 
cancer (mean reduction in risk of disease estimated above 20%). For the contrast, studies 
tracking the potential impact of physical activity on the onset of renal, testicular and bladder 
cancer have shown little or no effect on disease prevention. In addition, intensive physical 
training seems to be a factor promoting the development of prostate cancers. Mechanisms 
remain unclear, most probable is organ physical stimulation, impact of growth factors is also 
taken into account. The difficulty in conducting research on physical activity in the 
occurrence of lung cancer was related to the effects of cigarette smoking. Recreational 
training has an impact on the potential reduction of the risk, but it mainly concerns subjects 
who have never smoked. So far there is an inadequate scientific evidence on the impact of 
exercise in the prevention of hematologic diseases [7]. 
Physical activity is very often recommended in the cancer treatment process. 
Organizations such as the World Health Organization, the American Cancer Society, the 
American Institute for Cancer Research, the Australian Association for Excercising and 
Sports Science, and the American College of Sports Medicine have issued guidelines in which 
they postulate the inclusion of exercise in prevention programs and oncological treatment. Its 
undoubted benefit is the regulation of the psycho-somatic welfare of the patient, especially in 
prophylaxis and complete remissions of the disease [4, 7]. On the other hand, there is a direct 
correlation between tumour proliferation and insulin-like growth factors. Many pharmaceutics 
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work by cutting down the IGF pathway and thereby allowing tumour cells to enter apoptosis, 
autophagy or other programmed death processes [2, 5, 6, 9]. Despite the fact of IGFs direct 
influence on proliferation of tumours, high levels of IGF and IGFBP3 have been found to be 
positive prognosis predictors for some cancers. Attention was paid to the reduction of insulin 
resistance, endorphin ejection, increased prostaglandin production, decreased adipocytic 
reserve, and improved overall immune function [4, 8, 10]. Essential energy competition 
between neoplasms and normal tissues may be crucial in understanding complicated 
relationships in human metabolome. The tumour tissue significantly differes from normal one 
in the scope of presented receptors. It is therefore difficult to predict its response to growth 
factors present in the bloodstream. This unpredictability may be the reason for the inhibitory 
effect of IGF and IGFBP in the carcinogenesis process in some tumours [1, 3].  
Systemic defects presented by neoplastic cells cause not only changes in secretion of 
growth factors, but also aberrations in the reception of the signal carried by the molecule. 
According to this hypothesis, IGFs are not the cause of cancer, but only a potential modulator 
of its growth [1, 3, 7]. 
Concerning the general homeostasis of the body, it seems that the benefits of balanced 
physical exercise outweigh the potential risks caused by the secretion of growth factors. 
Individual adverse cases confirm the need for personalized treatment of each patient - careful 
monitoring of changes in the therapeutic process and rapid and effective response. In order to 
achieve this goal, careful comprehensive diagnostics are essential. 
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